Top Airlines Hit With Ticket Price-Fixing Class Action Lawsuit

A class action lawsuit filed Wednesday claims that the top U.S. airline carriers, which control more than 80 percent of the domestic travel market, conspired with each other in order to keep airfare prices artificially high. Lead plaintiffs Christopher Devivo, Jack Sniado and… Read More »

0

Mont. BNSF Railway Worker’s FELA Lawsuit Set for Retrial

In early June, the Montana Supreme Court called for stricter sanctions against BNSF Railway, the second largest freight railroad company in North America, which allegedly destroyed surveillance footage of a railroad accident involving one of their workers. The court has also called for... Read More »

0

Diabetes Medication Invokana May Carry Serious Risks

A recent investigation into Invokana side effects was launched after the FDA made an announcement on May 15 that suggested the drug contained unwarned side effects. Invokana and other diabetes medication may cause ketoacidosis and kidney failure, said the FDA announcement. What... Read More »

0

Why Is Cymbalta Withdrawal So Severe?

Doctors have prescribed Cymbalta to thousands of individuals suffering from depression. Although all antidepressants come with side effects, and many cause additional withdrawal symptoms, Cymbalta withdrawal has caused patients to experience extreme pain and suffering that often lasts long after the patient... Read More »

0

Antipsychotic Drug Risperdal Linked to Male Breast Growth

As many Americans are now aware, a certain antipsychotic has been linked to a peculiar side effect seen in young male patients. Risperdal (Risperidone) has received numerous allegations of inducing gynecomastia, or male breast growth, in young boys. Currently, there are 130... Read More »

0

FDA Advisors Recommend Onglyza Add Heart Failure Warning

An FDA advisory committee has recommended that the type-2 diabetes medication Onglyza should carry a new warning label that includes the increased risk of heart failure as a possible side effect. The U.S. Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory... Read More »

0

Parents Sue GlaxoSmithKline for Daughter’s Zofran Death

In another strike in the Zofran litigation movement, GlaxoSmithKline is facing a wrongful death lawsuit filed by a family who lost their baby girl due to severe cardiac defects. The family alleges that in direct result of the mother ingesting Zofran, the baby... Read More »

0

Xarelto Lawsuit Claims Life-Threatening GI Bleeding

A Tennessee couple has filed a lawsuit against the manufacturers of the blood thinning drug Xarelto (rivaroxaban), alleging that Bayer and Janssen Pharmaceuticals (a subsidiary of Johnson and Johnson) produced and marketed a dangerous and defective drug. In the Xarelto lawsuit, plaintiffs... Read More »

0

Calif. Care Facility Must Pay Workers $176K in Back Wages

A U.S. Labor Department investigation revealed that the owners of three California residential care facilities denied minimum wage and overtime to live-in employees. The labor department has required that the owners of Serene Care of Pleasanton, Calif.  pay their workers $176,000 in back... Read More »

0

Widow Files Eliquis Lawsuit for Husband’s Wrongful Death

An Alabama widow is pursuing an Eliquis lawsuit against Bristol-Meyer Squibb and Pfizer Inc., the drug’s manufacturers, alleging her husband used this popular new generation anti-coagulant and suffered extreme injuries that led to his untimely death. Plaintiff Willie Margaret Y. is filing... Read More »

0

401k Fee Disclosure May Not Be Enough

It’s not uncommon for workers to prudently set up a 401k retirement savings plan without being aware of the fees they’re being charged for that plan. The Department of Labor implemented rules in July 2012 requiring 401k plan providers to disclose certain... Read More »

0